Brexanolone (Zulresso) for Postpartum Depression
This Medical Letter reviews use of brexanolone, an intravenous γ-aminobutyric acid type A receptor modulator, approved by the US Food and Drug Administration for treatment of postpartum depression.
Source: JAMA - Category: General Medicine Source Type: research
More News: Depression | Food and Drug Administration (FDA) | General Medicine | Postnatal Depression